Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

ClinicalTrials.gov ID: NCT00920816

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00920816. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AG-013736 (AXITINIB) FOR THE TREATMENT OF METASTATIC RENAL CELL CANCER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer.

Study identification

NCT ID
NCT00920816
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
492 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2009 (Actual)
Primary completion
Jul 27, 2012 (Actual)
Completion
Apr 29, 2021 (Actual)
Last update posted
May 6, 2022

2009 – 2021

United States locations

U.S. sites
58
U.S. states
15
U.S. cities
42
Facility City State ZIP Site status
Advanced Medical Specialties Miami Florida 33143 —
Advanced Medical Specialties Miami Florida 33176 —
Illinois Cancer Specialists Arlington Heights Illinois 60005 —
Illinois Cancer Specialists Niles Illinois 60714 —
Indiana University Health Central Indiana Cancer Centers Carmel Indiana 46032 —
Indiana University Health Central Indiana Cancer Centers Fishers Indiana 46037 —
Indiana University Health Central Indiana Cancer Centers Greenfield Indiana 46140 —
Indiana University Health Central Indiana Cancer Centers Indianapolis Indiana 46219 —
Indiana University Health Central Indiana Cancer Centers Indianapolis Indiana 46227 —
Missouri Cancer Associates Columbia Missouri 65201 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052 —
US Oncology West Region Henderson Nevada 89052 —
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Hematology-Oncology Associates of Northern NJ, PA Morristown New Jersey 07962 —
Hematology-Oncology Associates of Northern NJ, PA Parsippany New Jersey 07054 —
New York Oncology Hematology, PC Albany New York 12206 —
New York Oncology Hematology, PC Albany New York 12208 —
New York Oncology Hematology, PC Latham New York 12110 —
New York Oncology Hematology, PC Rexford New York 12148 —
New York Oncology Hematology, PC Troy New York 12180 —
Raleigh Hematology Oncology Associates Cary North Carolina 27518 —
Raleigh Hematology Oncology Associates Raleigh North Carolina 27607 —
Raleigh Hematology Oncology Associates Raleigh North Carolina 27614 —
Northwest Cancer Specialists, PC Portland Oregon 97213 —
Northwest Cancer Specialists, PC Portland Oregon 97225 —
Northwest Cancer Specialists, PC Portland Oregon 97227 —
Northwest Cancer Specialists, PC Tualatin Oregon 97062 —
Penn State Milton S. Hershey Medical Center, Penn State Cancer Institute Hershey Pennsylvania 17033-0850 —
Medical University of South Carolina University Hospital Charleston South Carolina 29425 —
Medical University of South Carolina Charleston South Carolina 29425 —
Texas Oncology- Amarillo Amarillo Texas 79106 —
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center Beaumont Texas 77702-1449 —
Texas Oncology- Bedford Bedford Texas 76022 —
Texas Oncology- Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology- Fort Worth 12th Avenue Fort Worth Texas 76104 —
Texas Oncology- Southwest Fort Worth Fort Worth Texas 76132 —
Investigational Products Center (lPC) Fort Worth Texas 76177 —
US Oncology Research and Clinical Pharmacy Fort Worth Texas 76177 —
Texas Oncology - Grapevine Grapevine Texas 76051 —
Cancer Care Centers of South Texas Kerrville Texas 78028 —
Texas Oncology- McAllen South Second Street McAllen Texas 78503 —
Texas Oncology- Midland Allison Cancer Center Midland Texas 79701 —
Cancer Care Centers of South Texas San Antonio Texas 78217 —
Cancer Care Centers of South Texas San Antonio Texas 78258-3912 —
Texas Oncology-Deke Slayton Cancer Center Webster Texas 77598-4420 —
Texas Oncology-Weslaco Weslaco Texas 78596 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Christiansburg Virginia 24073 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Low Moor Virginia 24457 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Roanoke Virginia 24014 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Salem Virginia 24153 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Wytheville Virginia 24382 —
Northwest Cancer Specialists, PC Vancouver Washington 98684 —
Northwest Cancer Specialists, PC Vancouver Washington 98686 —
Wenatchee Valley Medical Center Wenatchee Washington 98801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00920816, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2022 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.